BioCentury
ARTICLE | Company News

Arena, Ferring Group deal

June 3, 2002 7:00 AM UTC

ARNA will use its Constitutively Activated Receptor Technology (CART) to develop for Ferring's Ferring Pharmaceuticals Inc. subsidiary an activated version of a GPCR target involved in reproductive bi...